Skip to content

The Effects of Cervical Stabilization Exercise Training With Telerehabilitation in Individuals With Migraine

The Effects of Cervical Stabilization Exercise Training With Telerehabilitation in Individuals With Migraine

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05202171
Enrollment
40
Registered
2022-01-21
Start date
2022-02-28
Completion date
2023-06-30
Last updated
2022-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Brief summary

The aim of our study is to investigate the effects of cervical stabilization exercise training applied with telerehabilitation in individuals with migraine.

Detailed description

Cervical muscles are adversely affected in individuals with migraine. It is important to investigate the effects of cervical muscle training in these individuals. Telerehabilitation applications have been used frequently in many patients in recent years. It is necessary to examine the effects of cervical stabilization exercises applied with telerehabilitation in individuals with migraine.

Interventions

Exercise group will be performed cervical stabilization exercise training applied with telerehabilitation and standard treatment ( preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine) for 8 weeks

OTHERStandard treatment

standard treatment will include preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine for 8 weeks

Sponsors

Ankara Yildirim Beyazıt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Being between the ages of 18-55, * To be diagnosed with migraine by a neurologist according to International Headache Society criteria, * Having at least 3 migraine attacks per month, * Volunteering to participate in the study, * Having the opportunity to access devices such as computers, phones and tablets with internet connection, * Not having any problems that prevent cooperation and understanding

Exclusion criteria

* Having other accompanying headache types, * Being pregnant, * Being in the breastfeeding period, * Having a history of trauma, fracture or surgery in the craniocervical region, * Presence of concomitant neurological and/or inflammatory rheumatic disease * Presence of serious psychiatric problems, * History of malignancy, * Changes in medical treatment during the study period, * Receiving physiotherapy for the cervical region in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
The characteristic of the migrainechange from baseline at 8 weeksThe characteristic of the migraine will be evaluated with the Headache Diary.

Secondary

MeasureTime frameDescription
Cranio-vertebral anglechange from baseline at 8 weeksThe cranio-vertebral angle will be measured with a goniometer
Disability Statuschange from baseline at 8 weeksThe Turkish version of Migraine Disability Assessment Scale will be used to determine the disability status in daily activities of individuals due to migraine
Sleep qualitychange from baseline at 8 weeksSleep quality will be evaluated with the Turkish version of Jenkins Sleep Scale
Performance of the deep neck flexor muscleschange from baseline at 8 weeksPerformance of the deep neck flexor muscles will be evaluated with a Stabilizer Pressure Biofeedback Unit
Cervical range of motionchange from baseline at 8 weeksCervical range of motion was evaluated using the goniometer
Upper cervical region movementschange from baseline at 8 weeksUpper cervical region movements will be evaluated with a Cervical Range of Motion device
Life qualitychange from baseline at 8 weeksLife quality will be evaluated with the Turkish version of Headache Impact Test

Contacts

Primary ContactSeyda Toprak Celenay
sydtoprak@hotmail.com+90312 906 1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026